Answers are grounded in this paper and cite their sources.
The automated detection of Alzheimer's Disease (AD) is increasingly critical for global healthcare systems, as conventional diagnostic pathways remain subjective, resource-intensive, and poorly scalable to resource-constrained clinical settings such as those prevalent in Indonesia. This study presents a rigorous comparative evaluation of three deep learning architectures - a custom Convolutional Neural Network (CNN), ResNet-50, and Vision Transformer (ViT/B-16)- for binary AD classification from Axial T1-weighted MRI. To assess genuine generalizability rather than in-distribution performance, a cross-dataset validation strategy was adopted: models were trained on the public dataset, i.e., the Falah/HuggingFace dataset, and then evaluated on the private dataset collected from Rumah Sakit Hasan Sadikin (RSHS), Bandung, Indonesia. To eliminate hyperparameter bias as a confounding variable, a systematic Grid Search across 27 configurations was conducted, combining three optimizers (Adam, SGD, and AdamW) with three learning rates (0.001, 0.0001, and 0.00001) per architecture. ResNet-50 with SGD at lr = 0.0001 emerged as the optimal configuration, achieving the highest internal accuracy of 0.989 (F1 = 0.980) and retaining a robust external accuracy of 0.823 (F1 = 0.825), surpassing all six prior benchmarked studies, none of which conducted external clinical validation. ViT exhibited severe domain sensitivity, collapsing from 0.985 internal to 0.617 external accuracy, a 37.36% degradation attributable to attention miscalibration under distribution shift. The Custom CNN achieved a moderate external accuracy of 0.653, outperforming ViT by 5.83% and confirming the structural advantage of convolutional inductive biases in limited-data regimes. These findings indicate that CNN-based architectures offer a safer, computationally more efficient, and clinically applicable solution for AD diagnosis compared to Transformer models, which rely heavily on large amounts of data.
No takes yet. Share an insight, caveat, or question.
Pardede et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: